Anti-beta Actin antibody [SP124] - Cytoskeleton Marker (Ab115777)
Beta-actin, ACTB
用户验证的应用
推荐稀释比例
- IHC-P1/200 Boil tissue section in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at room temperature for 20 min. Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB1/200
- ICC/IF1/50
- Flow Cyt (Intra)1/200 ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
详细信息
背景信息
What is this antibody validated in? Anti-beta Actin antibody [SP124] - Cytoskeleton Marker (ab115777) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of beta Actin? Anti-beta Actin [SP124] - Cytoskeleton Marker (ab115777) specifically detects a band for beta Actin (UniProt: P60709) at a molecular weight of 42kDa. Collaboration Anti-beta Actin [SP124] - Cytoskeleton Marker (ab115777) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC). Trusted by the scientific community Anti-beta Actin [SP124] - Cytoskeleton Marker (ab115777) was first used in a scientific publication in 2011 and has been cited over 140 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [SP124] also available for your convenience: ab115777, Carrier free - ab242387, Alexa Fluor® 488 - ab267526, ab279418, ab317794, Carrier free - ab317804 What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (236)
Deciphering the STAT3-PXN positive feedback loop in GBM, IDH-wildtype: transcriptional regulation and inhibition of YB-1 ubiquitination.
解读 GBM 中 STAT3-PXN 正反馈环路,IDH 野生型:转录调控和 YB-1 泛素化的抑制。
Investigating the Therapeutic Efficacy of Quality-Controlled, miR-146a-5p-Enriched Small Extracellular Vesicles Derived From MSCs Against Idiopathic Pulmonary Fibrosis.
研究质量控制的、富含 miR-146a-5p 的 MSC 来源的小细胞外囊泡对特发性肺纤维化的治疗效果。
Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status.
药物抑制 GSK3β 后对脑出血的神经保护作用取决于 HFE 基因状态。
KLF2 inhibits keloid progression by targeting PI3K/AKT-mediated MMP-2/9 signaling.
KLF2 通过靶向 PI3K/AKT 介导的 MMP-2/9 信号通路来抑制瘢痕疙瘩的进展。
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
在癌症实验模型中,通过定制化学诱变诱导错配修复缺陷基因型。
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism.
人类肠道中常见细菌合成的多肽可以改善啮齿动物的新陈代谢
SIRT6 Lysine-Demyristoylates ATF2 to Ameliorate Vascular Injury via PRKCD/VE-Cadherin Pathway Regulating Vascular Endothelial Barrier.
SIRT6 赖氨酸脱肉豆蔻酰化 ATF2 通过 PRKCD/VE-钙黏蛋白通路调节血管内皮屏障,从而改善血管损伤。
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
用阿伐替尼靶向抑制 PDGFRA,可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效:临床意义
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
CHCHD2突变小鼠将线粒体缺陷与帕金森病病理生理学联系起来
Catalytic neural stem cell exosomes for multi-stage targeting and synergistical therapy of retinal ischemia-reperfusion injury.
催化性神经干细胞外泌体用于视网膜缺血再灌注损伤的多阶段靶向和协同治疗
- 1
- 2
- 3
- 4
- 5
- 6
- 24